Search
for
Sort by
Research 301–330 of 1000+
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata
- HrQoL in hair loss‐affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study
- Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata
- Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Insulin resistance is increased in alopecia areata patients
- Association of Sensorineural Hearing Loss in Patients With Alopecia Areata
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Serum level of vitamin D in patients with alopecia areata
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part II Systemic Treatment
- Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Successful hair regrowth in an acute diffuse form of alopecia areata during oral tacrolimus treatment in a patient with rheumatoid arthritis